广发纳斯达克生物科技人民币(001092)

动态评分: 5.30分

投资组合

报告日期 名称 比例
2023-12-31 iTeos Therapeutics Inc 0.04%
2023-12-31 Fulcrum Therapeutics Inc 0.04%
2023-12-31 Oric Pharmaceuticals Inc 0.04%
2023-12-31 MaxCyte Inc 0.04%
2023-12-31 MeiraGTx Holdings plc 0.04%
2023-12-31 Arbutus Biopharma Corp 0.04%
2023-12-31 Third Harmonic Bio Inc 0.04%
2023-12-31 Lyell Immunopharma Inc 0.04%
2023-12-31 Nurix Therapeutics Inc 0.04%
2023-12-31 Cullinan Oncology Inc 0.04%
2023-12-31 Arcutis Biotherapeutics Inc 0.03%
2023-12-31 Coherus BioSciences Inc 0.03%
2023-12-31 Ocular Therapeutix Inc 0.03%
2023-12-31 Precigen Inc 0.03%
2023-12-31 uniQure NV 0.03%
2023-12-31 Terns Pharmaceuticals Inc 0.03%
2023-12-31 Humacyte Inc 0.03%
2023-12-31 Erasca Inc 0.03%
2023-12-31 Xeris制药 0.03%
2023-12-31 Mineralys Therapeutics Inc 0.03%

投资模拟

公告&资料